Blauvelt, A, B Strober, R Langley, D Burge, L Pisenti, M Yassine, S Kavanagh, C Arendt, R Rolleri, and K Reich. 2018. “Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies”. SKIN The Journal of Cutaneous Medicine 2 (S1):S16. https://doi.org/10.25251/skin.2.supp.16.